Congenital diseases in children refer to structural, functional, or metabolic abnormalities present at birth, which may be caused by genetic factors, maternal environmental influences during pregnancy, or a combination of both. These conditions require timely diagnosis and standardized intervention to improve the child’s quality of life and long-term prognosis. Below is a detailed overview of nine common pediatric congenital diseases:
1. Hypospadias
Overview
Hypospadias is a common congenital urinary tract malformation in males, characterized by the urethral meatus opening on the ventral side of the penis (instead of the tip). It affects approximately 1 in 300 male infants.
Etiology
Genetic predisposition, maternal hormone imbalance during pregnancy (e.g., exposure to exogenous estrogen), and prenatal exposure to certain medications (e.g., some anticonvulsants) are key risk factors.
Clinical Manifestations
- Abnormal location of the urethral meatus (ranging from the glans to the scrotum).
- Curvature of the penis (chordee) during erection.
- Difficulty urinating (e.g., spraying urine stream, incomplete emptying).
Diagnosis & Treatment
- Diagnosis: Confirmed by physical examination after birth; ultrasound may be performed to rule out associated urinary tract abnormalities.
- Treatment: Surgical correction is the mainstay, typically performed between 6 and 18 months of age. The goal is to reposition the urethral meatus to the tip of the penis and correct penile curvature.
2. Congenital Hydronephrosis
Overview
Congenital hydronephrosis is the dilation of the renal pelvis and calyces due to obstruction of urinary flow, which may damage renal function if left untreated. It is one of the most common abnormalities detected by prenatal ultrasound (incidence: 1-5 per 1,000 live births).
Etiology
The most common cause is ureteropelvic junction (UPJ) obstruction, followed by ureterovesical junction (UVJ) obstruction, posterior urethral valves (in males), and vesicoureteral reflux.
Clinical Manifestations
- Prenatal: Detected incidentally by routine ultrasound.
- Postnatal: Abdominal mass, recurrent urinary tract infections (UTIs), hematuria, or failure to thrive in severe cases.
Diagnosis & Treatment
- Diagnosis: Prenatal ultrasound screening; postnatal follow-up with renal ultrasound, voiding cystourethrogram (VCUG), and renal scintigraphy to assess obstruction severity and renal function.
- Treatment: Conservative management (regular monitoring) for mild cases; surgical intervention (e.g., pyeloplasty for UPJ obstruction) for severe or progressive hydronephrosis to relieve obstruction and preserve renal function.
3. Congenital Hydrocephalus
Overview
Congenital hydrocephalus is characterized by excessive accumulation of cerebrospinal fluid (CSF) in the ventricular system of the brain, leading to increased intracranial pressure and ventricular dilation. It affects 1-3 per 1,000 live births.
Etiology
Causes include neural tube defects (e.g., myelomeningocele), aqueductal stenosis (narrowing of the CSF pathway), intraventricular hemorrhage, and congenital infections (e.g., cytomegalovirus, CMV).
Clinical Manifestations
- Infants: Rapid head growth (faster than normal), bulging fontanelle, sunset eyes (downward deviation of the eyes), irritability, poor feeding, and developmental delay.
- Older children: Headache, vomiting, blurred vision, and gait abnormalities.
Diagnosis & Treatment
- Diagnosis: Prenatal ultrasound; postnatal cranial ultrasound, computed tomography (CT), or magnetic resonance imaging (MRI) to confirm ventricular dilation and identify the cause.
- Treatment: Surgical placement of a shunt (e.g., ventriculoperitoneal shunt) to divert excess CSF to the abdomen; endoscopic third ventriculostomy (ETV) is an alternative for selected cases.
4. Neural Tube Defects (NTDs)
Overview
Neural tube defects are congenital malformations of the central nervous system (CNS) resulting from incomplete closure of the neural tube during embryonic development (3-4 weeks of gestation). Common types include anencephaly, myelomeningocele, and spina bifida occulta.
Etiology
Low maternal folic acid intake before and during early pregnancy is the primary modifiable risk factor. Other factors include genetic mutations, maternal diabetes, obesity, and exposure to teratogens (e.g., valproic acid, alcohol).
Clinical Manifestations
- Anencephaly: Absence of major portions of the brain and skull; fatal shortly after birth.
- Myelomeningocele: Protrusion of the spinal cord and meninges through a defect in the vertebral column; associated with motor and sensory deficits (e.g., paraplegia), bladder/bowel dysfunction, and hydrocephalus.
- Spina Bifida Occulta: Mild defect with no protrusion; often asymptomatic, but may cause back pain or urinary issues in some cases.
Diagnosis & Treatment
- Diagnosis: Prenatal screening via maternal serum alpha-fetoprotein (AFP) testing and ultrasound; prenatal diagnosis confirmed by amniocentesis.
- Treatment: Myelomeningocele requires urgent surgical repair within 24-48 hours of birth to protect the spinal cord; long-term management includes physical therapy, shunt placement for hydrocephalus, and urological care.
5. Cleft Lip and Palate
Overview
Cleft lip and palate are common congenital orofacial malformations, characterized by incomplete fusion of the lip and/or palate during embryonic development (4-12 weeks of gestation). They occur in approximately 1 per 700 live births, with higher incidence in Asian and Native American populations.
Etiology
Combination of genetic and environmental factors: family history of clefts, maternal smoking/alcohol consumption during pregnancy, maternal vitamin deficiency (e.g., folic acid, vitamin B12), and maternal infections (e.g., rubella).
Clinical Manifestations
- Cleft Lip: Gap in the upper lip (unilateral or bilateral), which may extend to the nose.
- Cleft Palate: Gap in the hard or soft palate (isolated or combined with cleft lip); affects feeding, speech, and dental development.
- Associated issues: Difficulty breastfeeding/bottle-feeding, recurrent ear infections, hearing loss, and speech articulation problems.
Diagnosis & Treatment
- Diagnosis: Prenatal ultrasound (detects most cleft lips); postnatal physical examination confirms cleft palate.
- Treatment: Multidisciplinary approach:
◦Cleft lip repair: 3-6 months of age.
◦Cleft palate repair: 6-12 months of age.
◦Long-term care includes speech therapy, orthodontic treatment, and psychological support.
6. Congenital Heart Disease (CHD)
Overview
Congenital heart disease refers to structural abnormalities of the heart or great vessels present at birth, being the most common congenital defect worldwide (incidence: 8-10 per 1,000 live births). Common types include ventricular septal defect (VSD), atrial septal defect (ASD), tetralogy of Fallot (TOF), and transposition of the great arteries (TGA).
Etiology
Genetic factors (e.g., Down syndrome, Turner syndrome), maternal infections during pregnancy (e.g., rubella, Zika virus), maternal chronic diseases (e.g., diabetes, lupus), and prenatal exposure to teratogens (e.g., alcohol, certain medications).
Clinical Manifestations
- Severe cases (e.g., TGA): Cyanosis (bluish discoloration of skin/mucous membranes), difficulty breathing, poor feeding, and heart failure shortly after birth.
- Mild cases (e.g., small VSD): Asymptomatic, detected incidentally during routine physical examination (e.g., heart murmur).
- Other symptoms: Growth retardation, fatigue, and recurrent respiratory infections.
Diagnosis & Treatment
- Diagnosis: Prenatal ultrasound (fetal echocardiogram) for high-risk pregnancies; postnatal diagnosis via physical examination, electrocardiogram (ECG), chest X-ray, and echocardiogram.
- Treatment:
◦Conservative management (regular monitoring) for small, asymptomatic defects that may close spontaneously.
◦Surgical correction (e.g., defect closure, arterial switch operation) for severe or symptomatic defects.
Catheter-based interventions (e.g., balloon valvuloplasty) for selected cases.
7. Congenital Esophageal Atresia with Tracheoesophageal Fistula (EA-TEF)
Overview
EA-TEF is a life-threatening congenital malformation of the upper gastrointestinal tract, characterized by a blind-ending esophagus and an abnormal connection (fistula) between the esophagus and trachea. It occurs in approximately 1 per 3,000 live births.
Etiology
Abnormal embryonic development of the foregut (4-6 weeks of gestation); associated with other congenital defects in 50% of cases (e.g., VACTERL association: Vertebral anomalies, Anal atresia, Cardiac defects, Tracheoesophageal fistula, Esophageal atresia, Renal anomalies, Limb anomalies).
Clinical Manifestations
- Immediate postnatal symptoms: Excessive salivation, coughing, choking, and cyanosis during feeding (milk enters the trachea via the fistula).
- Risk of aspiration pneumonia and respiratory failure without prompt intervention.
Diagnosis & Treatment
- Diagnosis: Clinical suspicion based on postnatal symptoms; confirmed by inability to pass a nasogastric tube into the stomach and chest X-ray (showing the tube coiled in the blind esophagus).
- Treatment: Emergency surgical repair within the first few days of life to disconnect the fistula and anastomose the esophageal segments; preoperative care includes airway management, suctioning of secretions, and intravenous nutrition.
8. Congenital Biliary Atresia
Overview
Congenital biliary atresia is a progressive cholestatic liver disease characterized by obstruction or absence of the extrahepatic bile ducts, leading to bile accumulation, liver fibrosis, and cirrhosis if untreated. It affects 1 per 10,000-15,000 live births, with higher incidence in females and East Asian populations.
Etiology
Unknown; proposed factors include viral infections (e.g., reovirus, rotavirus), autoimmune reactions, and genetic predisposition.
Clinical Manifestations
- Initial 2-4 weeks: Normal appearance (bile ducts may still be partially functional).
- Subsequent symptoms: Jaundice (persistent yellowing of skin/eyes), dark urine, pale (clay-colored) stools, hepatomegaly (enlarged liver), and failure to thrive.
Diagnosis & Treatment
- Diagnosis: Laboratory tests (elevated bilirubin, liver enzymes), abdominal ultrasound (small or absent gallbladder), hepatobiliary scintigraphy, and liver biopsy.
- Treatment:
◦Kasai portoenterostomy: Surgical procedure (performed before 60-90 days of age) to create a connection between the liver and intestine, allowing bile drainage.
◦Liver transplantation: Required for patients with failed Kasai procedure or progressive liver cirrhosis (the most common indication for pediatric liver transplantation).
9. Developmental Dysplasia of the Hip (DDH)
Overview
DDH (formerly congenital hip dysplasia) refers to abnormal development of the hip joint, including instability, subluxation (partial dislocation), or dislocation of the femoral head from the acetabulum. It affects 1-3 per 1,000 live births, with higher incidence in females, firstborn children, and infants with breech presentation.
Etiology
Hormonal factors (maternal relaxin causing ligament laxity), mechanical factors (breech position, swaddling with legs extended), and genetic predisposition.
Clinical Manifestations
- Infants: Asymmetry of leg lengths, limited abduction of the hip (inability to spread legs wide), and clicking sound during hip movement (Ortolani test).
- Older children: Limping, waddling gait, or hip pain (in untreated cases).
Diagnosis & Treatment
- Diagnosis: Neonatal physical examination (Ortolani and Barlow tests); ultrasound screening (gold standard for infants ); X-ray for children >6 months (when the femoral head ossifies).
- Treatment:
◦Infants Pavlik harness (maintains hip in abducted position to promote acetabular development).
◦Children 6-18 months: Closed reduction with hip spica casting, or open reduction for severe cases.
◦Older children: Osteotomy (surgical reshaping of the hip bones) to improve joint stability.
Conclusion
Pediatric congenital diseases vary in severity and impact, but early screening, timely diagnosis, and multidisciplinary intervention are critical to optimizing outcomes. Prenatal care (e.g., folic acid supplementation, avoiding teratogens) plays a key role in preventing some congenital defects. For children with confirmed conditions, coordinated care from pediatricians, surgeons, therapists, and other specialists ensures comprehensive management and improves long-term quality of life.
Content & functions powered by Doubao AI.